InvestorsHub Logo
Followers 22
Posts 7075
Boards Moderated 0
Alias Born 05/14/2011

Re: None

Monday, 09/24/2018 5:36:57 PM

Monday, September 24, 2018 5:36:57 PM

Post# of 58855
It's a stretch, but maybe a reason for our drop today. Last Friday's news to us, just LANDING on SEC's EDGAR site. Last Friday's rise may be attributed to electronic algorithm triggers too.

Not a lot of reason on last week's rise. MORE NEWS NEEDED JIM HEYWARD.

The following excerpt is from the company's SEC filing just completed.
Rehash of last week.

5:10 PM (14 minutes ago)
Greetings mcsharkey@
Applied DNA Sciences Inc. (APDN) just filed a Current report, items 7.01 and 9.01
.


Applied DNA Sciences: Applied DNA Subsidiary, Linearx, Inc. Signs Joint Development
Agreement with Takis and Evvivax to Develop Linear-DNA Based Anti-Cancer Vaccines
Collaboration Seeks to Develop PCR-produced Linear DNA as a Safer Expression Vector for Vaccines
STONY BROOK N.Y., September 20, 2018

Applied DNA Sciences Inc. (NASDAQ: APDN) (Applied DNA or the Company) announced today that LineaRx, Inc. (LineaRx), its wholly-owned subsidiary focused on next-generation biotherapeutics, has signed a Joint Development Agreement (the Agreement) with Takis S.R.L. and Evvivax S.R.L. (Takis/Evvivax), biotechnology companies focused on the discovery and development of DNA based anti-cancer vaccines for the human and animal markets, respectively.....

Holding, and that's reckless.
GLTUA
VR
Mike Sharkey
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent APDN News